#BEGIN_DRUGCARD DB07416

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
Not Available

# Chemical_Formula:
C16H30O5

# Chemical_IUPAC_Name:
(2S)-2-(butanoyloxy)-3-hydroxypropyl nonanoate

# Chemical_Structure:
Not Available

# Creation_Date:
2010-09-15 15:21:28 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
(2S)-2-(BUTYRYLOXY)-3-HYDROXYPROPYL NONANOATE

# HET_ID:
B3H

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C16H30O5/c1-3-5-6-7-8-9-11-15(18)20-13-14(12-17)21-16(19)10-4-2/h14,17H,3-13H2,1-2H3/t14-/m0/s1

# InChI_Key:
InChIKey=JCEXPOMAGTUEEX-AWEZNQCLSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
Not Available

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
7422

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
302.4064

# Molecular_Weight_Mono:
302.20932407

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
Not Available

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
3.32

# Predicted_LogS:
-3.6

# Predicted_Water_Solubility:
7.21e-02 g/l

# Primary_Accession_No:
DB07416

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
448271

# PubChem_Substance_ID:
99443887

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
Not Available

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
[H][C@](CO)(COC(=O)CCCCCCCC)OC(=O)CCC

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:25:36 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Cell membrane
multi-pass membrane protein

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
Z37969

# Drug_Target_1_GenBank_ID_Protein:
1089906

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
kcsA

# Drug_Target_1_Gene_Sequence:
>483 bp
ATGCCACCCATGCTGTCCGGTCTTCTGGCCAGATTGGTCAAACTGCTGCTCGGGCGCCAC
GGCAGTGCGCTGCACTGGAGGGCCGCGGGTGCCGCGACGGTCCTCCTGGTGATCGTCCTC
CTCGCGGGCTCGTACTTGGCCGTCCTGGCTGAGCGCGGCGCACCGGGCGCGCAGCTGATC
ACGTATCCGCGGGCGCTGTGGTGGTCCGTGGAGACCGCGACGACCGTCGGCTACGGCGAC
CTGTACCCCGTGACTCTGTGGGGCCGGCTCGTGGCCGTGGTGGTGATGGTCGCCGGGATC
ACCTCCTTCGGTCTGGTGACCGCCGCGCTGGCCACCTGGTTCGTCGGCCGGGAACAAGAG
CGCCGGGGCCACTTCGTGCGCCACTCCGAGAAGGCCGCCGAGGAGGCGTACACGCGGACG
ACCCGGGCGCTGCACGAGCGTTTCGACCGTTTGGAGCGAATGCTCGACGACAACCGCCGG
TGA

# Drug_Target_1_General_Function:
Inorganic ion transport and metabolism

# Drug_Target_1_General_References:
10757971	le Coutre J, Whitelegge JP, Gross A, Turk E, Wright EM, Kaback HR, Faull KF: Proteomics on full-length membrane proteins using mass spectrometry. Biochemistry. 2000 Apr 18;39(15):4237-42.
11158168	Cortes DM, Cuello LG, Perozo E: Molecular architecture of full-length KcsA: role of cytoplasmic domains in ion permeation and activation gating. J Gen Physiol. 2001 Feb;117(2):165-80.
11573095	Liu YS, Sompornpisut P, Perozo E: Structure of the KcsA channel intracellular gate in the open state. Nat Struct Biol. 2001 Oct;8(10):883-7.
11689935	Morais-Cabral JH, Zhou Y, MacKinnon R: Energetic optimization of ion conduction rate by the K+ selectivity filter. Nature. 2001 Nov 1;414(6859):37-42.
11689936	Zhou Y, Morais-Cabral JH, Kaufman A, MacKinnon R: Chemistry of ion coordination and hydration revealed by a K+ channel-Fab complex at 2.0 A resolution. Nature. 2001 Nov 1;414(6859):43-8.
7489706	Schrempf H, Schmidt O, Kummerlen R, Hinnah S, Muller D, Betzler M, Steinkamp T, Wagner R: A prokaryotic potassium ion channel with two predicted transmembrane segments from Streptomyces lividans. EMBO J. 1995 Nov 1;14(21):5170-8.
9525859	Doyle DA, Morais Cabral J, Pfuetzner RA, Kuo A, Gulbis JM, Cohen SL, Chait BT, MacKinnon R: The structure of the potassium channel: molecular basis of K+ conduction and selectivity. Science. 1998 Apr 3;280(5360):69-77.
9782060	Gouaux E: Single potassium ion seeks open channel for transmembrane travels: tales from the KcsA structure. Structure. 1998 Oct 15;6(10):1221-6.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2472

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
17694

# Drug_Target_1_Name:
Voltage-gated potassium channel

# Drug_Target_1_Number_of_Residues:
160

# Drug_Target_1_PDB_ID:
1F6G

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF07885	Ion_trans_2

# Drug_Target_1_Protein_Sequence:
>Voltage-gated potassium channel
MPPMLSGLLARLVKLLLGRHGSALHWRAAGAATVLLVIVLLAGSYLAVLAERGAPGAQLI
TYPRALWWSVETATTVGYGDLYPVTLWGRLVAVVVMVAGITSFGLVTAALATWFVGREQE
RRGHFVRHSEKAAEEAYTRTTRALHERFDRLERMLDDNRR

# Drug_Target_1_Reaction:
Not Available

# Drug_Target_1_Signals:
None

# Drug_Target_1_Specific_Function:
Acts as a potassium ion channel

# Drug_Target_1_SwissProt_ID:
P0A334

# Drug_Target_1_SwissProt_Name:
KCSA_STRLI

# Drug_Target_1_Synonyms:
Not Available

# Drug_Target_1_Theoretical_pI:
10.66

# Drug_Target_1_Transmembrane_Regions:
28-50
88-111

# Drug_Target_2_Cellular_Location:
Not Available

# Drug_Target_2_Chromosome_Location:
2

# Drug_Target_2_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_2_Essentiality:
Non-Essential

# Drug_Target_2_GenAtlas_ID:
Not Available

# Drug_Target_2_GenBank_ID_Gene:
J00241

# Drug_Target_2_GenBank_ID_Protein:
185945

# Drug_Target_2_GeneCard_ID:
IGKC

# Drug_Target_2_Gene_Name:
IGKC

# Drug_Target_2_Gene_Sequence:
Not Available

# Drug_Target_2_General_Function:
Involved in antigen binding

# Drug_Target_2_General_References:
4893682	Titani K, Shinoda T, Putnam FW: The amino acid sequence of a kappa type Bence-Jones protein. 3. The complete sequence and the location of the disulfide bridges. J Biol Chem. 1969 Jul 10;244(13):3550-60.
4923144	Gall WE, Edelman GM: The covalent structure of a human gamma G-immunoglobulin. X. Intrachain disulfide bonds. Biochemistry. 1970 Aug 4;9(16):3188-96.
5027703	Suter L, Barnikol HU, Watanabe S, Hilschmann N: [Rule of antibody structure. The primary structure of a monoclonal immunoglobulin L-chain of kappa-type, subgroup 3 (Bence-Jones protein Ti). IV. The complete amino acid sequence and its significance for the mechanism of antibody production] Hoppe Seylers Z Physiol Chem. 1972 Feb;353(2):189-208.
5447531	Kohler H, Shimizu A, Paul C, Putnam FW: Macroglobulin structure: variable sequence of light and heavy chains. Science. 1970 Jul 3;169(940):56-9.
5489770	Gottlieb PD, Cunningham BA, Rutishauser U, Edelman GM: The covalent structure of a human gamma G-immunoglobulin. VI. Amino acid sequence of the light chain. Biochemistry. 1970 Aug 4;9(16):3155-61.
5586923	Hilschmann N: [The complete amino acid sequence of Bence Jones protein Cum (kappa-type)] Hoppe Seylers Z Physiol Chem. 1967 Dec;348(12):1718-22.
6775818	Hieter PA, Max EE, Seidman JG, Maizel JV Jr, Leder P: Cloned human and mouse kappa immunoglobulin constant and J region genes conserve homology in functional segments. Cell. 1980 Nov;22(1 Pt 1):197-207.
9588180	Olsen KE, Sletten K, Westermark P: Extended analysis of AL-amyloid protein from abdominal wall subcutaneous fat biopsy: kappa IV immunoglobulin light chain. Biochem Biophys Res Commun. 1998 Apr 28;245(3):713-6.

# Drug_Target_2_HGNC_ID:
GNC:5716

# Drug_Target_2_HPRD_ID:
Not Available

# Drug_Target_2_ID:
6338

# Drug_Target_2_Locus:
2p12

# Drug_Target_2_Molecular_Weight:
11608.8

# Drug_Target_2_Name:
Ig kappa chain C region

# Drug_Target_2_Number_of_Residues:
106

# Drug_Target_2_PDB_ID:
1N8Z

# Drug_Target_2_Pathway:
Not Available

# Drug_Target_2_Pfam_Domain_Function:
PF07654	C1-set

# Drug_Target_2_Protein_Sequence:
>Ig kappa chain C region
TVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDS
KDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC

# Drug_Target_2_Reaction:
Not Available

# Drug_Target_2_Signals:
None

# Drug_Target_2_Specific_Function:
Not Available

# Drug_Target_2_SwissProt_ID:
P01834

# Drug_Target_2_SwissProt_Name:
IGKC_HUMAN

# Drug_Target_2_Synonyms:
Not Available

# Drug_Target_2_Theoretical_pI:
5.68

# Drug_Target_2_Transmembrane_Regions:
None

# Drug_Target_3_Cellular_Location:
Cell membrane

# Drug_Target_3_Chromosome_Location:
Not Available

# Drug_Target_3_Drug_References:
10592235	Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.

# Drug_Target_3_Essentiality:
Essential

# Drug_Target_3_GenAtlas_ID:
Not Available

# Drug_Target_3_GenBank_ID_Gene:
AL939132

# Drug_Target_3_GenBank_ID_Protein:
7799279

# Drug_Target_3_GeneCard_ID:
kcsA

# Drug_Target_3_Gene_Name:
kcsA

# Drug_Target_3_Gene_Sequence:
>1275 bp
TTGACCGGCATGCAGATGCCCAGCGGAGTGCACGCACTGGTCAGGCGGACCCACGAAGAG
CGCGTCATGCGTGCGCTGCAGGAGAACGGCGCCATGAGCCGGGGCGAGATCGCCCGGGTC
GTGGGCCTGTCCCGCACCACCCTGTCCGAGATCACCGGCAACCTCCTGCAACGCGGTGCC
ATCGTGGTCGTCGACACCGACGCCTCCCGCCGCGAGGGCAGCGGGCGGCCGGCCGAACGG
CTGGCGCTCGACCCGGCGTCGGCGCAGTTCATGGGCGTCGACTTCGGACACCGGCGCGTC
CACGTCGTCGTCGCCGACGCCGCGCACGAGATCATGGTCTCCGGCTCCGTCCGGTACGAG
GACACCGCGACCTGGCCGACCCGCACGGAACGGGCCCTGGAACTGGTCGACCGGCTCAGC
GGCGAGGCCGGGGTCCACTACGGGGCGTTGCAGGGCATCGGCATCGGCGTACCCGGTCCC
TACCCGGCTCCGGAGGGGGCGGCCTGGCCGCGCGCCACCCCGGGCACCACGGTGCTGCGC
CCGGCACCCGAGGGCGTCGACGTGGCCTTCGCCGAACGCTTCGACGCACCGGTCATCGTC
GACAACAACACCCGGCTGGCCGCCCTCGCCGAGGCGATCAGCGGCGCCGACAGCGTCGCC
GACCTGGTCTACGTACGCCTGTCGGACGGCGTCGGCGGCGGACTCGTCGTCGGGGGCCAG
CTGGTGACGGGTTCGTCCGGGCTGGCCGGCGAGCTGGGACACGTGACCGTGGAACCGGCG
GGCCGCCCCTGTCGCTGCGGCAAGCGGGGCTGCCTGGAGACCGTGGCCTCGGTGCCCGGA
ATCCTCGCCGCCTGCTGGGAGTTCGGCCTGCGCCTGGAGAACCTCGACGACCTCGCCGCC
GCCGTGCGCCGCGCCCACCCCGTCGTGGACCGGGTGCTGCGGGAGGCCGCGGGGGCGCTG
GGCCGGGTGGTCGGCGCCGCGACCATGATGCTGAACCCGGCGAAGGTGGTCATCGGCGGC
GAGATCACCCGGCTGGCGCCCGTCCTCGTGGAACAGGTCGCCGCCACCCTCGCCGCCGAG
ATCTTCCCGACCGCCTCGGCGGGACCCGTCGTGGCCGCCGCCCGGCTCTCCGACGACGAC
GGCGCCATCGGCGCGCTCGCCGCGGTCTTCCACAGCTCACCCCTCCTGGCGAGGTATCCC
GAAACCGCCGACGTGAAGGGCCGTTCCGATGCACCCCACTCCGCCACCGAAGGAGCCGCC
CATGTCCGTCCTTGA

# Drug_Target_3_General_Function:
Inorganic ion transport and metabolism

# Drug_Target_3_General_References:
12000953	Bentley SD, Chater KF, Cerdeno-Tarraga AM, Challis GL, Thomson NR, James KD, Harris DE, Quail MA, Kieser H, Harper D, Bateman A, Brown S, Chandra G, Chen CW, Collins M, Cronin A, Fraser A, Goble A, Hidalgo J, Hornsby T, Howarth S, Huang CH, Kieser T, Larke L, Murphy L, Oliver K, O'Neil S, Rabbinowitsch E, Rajandream MA, Rutherford K, Rutter S, Seeger K, Saunders D, Sharp S, Squares R, Squares S, Taylor K, Warren T, Wietzorrek A, Woodward J, Barrell BG, Parkhill J, Hopwood DA: Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2). Nature. 2002 May 9;417(6885):141-7.

# Drug_Target_3_HGNC_ID:
Not Available

# Drug_Target_3_HPRD_ID:
Not Available

# Drug_Target_3_ID:
6366

# Drug_Target_3_Locus:
Not Available

# Drug_Target_3_Molecular_Weight:
17693.5

# Drug_Target_3_Name:
Voltage-gated potassium channel

# Drug_Target_3_Number_of_Residues:
160

# Drug_Target_3_PDB_ID:
1F6G

# Drug_Target_3_Pathway:
Not Available

# Drug_Target_3_Pfam_Domain_Function:
PF07885	Ion_trans_2

# Drug_Target_3_Protein_Sequence:
>Voltage-gated potassium channel
MPPMLSGLLARLVKLLLGRHGSALHWRAAGAATVLLVIVLLAGSYLAVLAERGAPGAQLI
TYPRALWWSVETATTVGYGDLYPVTLWGRLVAVVVMVAGITSFGLVTAALATWFVGREQE
RRGHFVRHSEKAAEEAYTRTTRALHERFDRLERMLDDNRR

# Drug_Target_3_Reaction:
Not Available

# Drug_Target_3_Signals:
None

# Drug_Target_3_Specific_Function:
Acts as a potassium ion channel (By similarity)

# Drug_Target_3_SwissProt_ID:
P0A333

# Drug_Target_3_SwissProt_Name:
KCSA_STRCO

# Drug_Target_3_Synonyms:
Not Available

# Drug_Target_3_Theoretical_pI:
10.66

# Drug_Target_3_Transmembrane_Regions:
28-50
88-111

#END_DRUGCARD DB07416
